查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1716297

2032 年疫苗储存和包装市场预测：按产品类型、包装材料、疫苗类型、应用、最终用户和地区进行的全球分析

Vaccine Storage & Packaging Market Forecasts to 2032 - Global Analysis By Product Type, Packaging Material, Vaccine Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球疫苗储存和包装市场预计在 2025 年达到 400.6 亿美元，到 2032 年将达到 885.7 亿美元，预测期内的复合年增长率为 12.0%。

疫苗的储存和包装对于从生产到管理维持疫苗的有效性和安全性起着至关重要的作用。适当的储存条件，尤其是温度控制，对于保持疫苗的有效性至关重要，因此低温运输物流（即确保疫苗保持在指定温度范围内的冷却系统）至关重要。此外，防篡改密封和温度敏感标籤等包装创新提高了可追溯性和安全性。随着全球疫苗接种工作的扩大，尤其是在偏远和欠发达地区，对可靠、有效且永续的疫苗储存和包装解决方案的需求可能会成长。

根据泛美卫生组织 (PAHO) 介绍，疫苗管瓶监测器 (VVM) 是一种发烧指示器，当暴露于超过指定阈值的温度时会改变颜色。 VVM 有五种类型，每种类型都是根据特定疫苗的热稳定性而设计的。这些 VVM 根据三个温度阈值进行分类：37°C、25°C 和 5°C。

加强全球疫苗接种倡议

推动疫苗储存和包装市场的主要因素之一是已开发经济体和新兴经济体疫苗宣传活动的扩大。世界卫生组织 (WHO)、全球疫苗免疫联盟和联合国儿童基金会等组织每年花费数十亿美元用于大规模疫苗宣传活动，以对抗麻疹、脊髓灰质炎、HPV 和 COVID-19 等疾病。例如，截至2023年，Gavi已为超过9.81亿名儿童接种了疫苗。此外，这些努力推动了对专门的储存系统、保护性包装解决方案和可靠的供应链的需求，这些供应链具有严格的温度和安全控制，以确保疫苗的有效性。

营运和资本成本高

疫苗储存系统，尤其是采用超低温物流的物流，建立维护成本很高。专用冷冻库、保温容器和监测设备的购买和运作成本很高，尤其是在资源有限的环境中。此外，维持恆定低温所需的电力会增加经常性营运成本。例如，每台超低温 (ULT)冷冻库的成本在 10,000 美元到 25,000 美元之间，并且比传统冷冻系统消耗更多的能源。此外，这些成本可能会限制采用，特别是在资源和基础设施有限的开发中国家、小型医院和农村诊所。

智慧包装的先进技术

即时监控感测器、RFID 标籤、温度敏感标籤和二维码可追溯性是一些越来越普及的智慧包装解决方案。这些技术将提高供应链透明度，减少人为错误并提高安全性。例如，世卫组织支持的疫苗接种宣传活动现在经常使用疫苗管瓶监测仪（VVM），仪器遇热会变色。此外，透过将物联网和基于人工智慧的追踪整合到包装中，公司现在可以采用新的方式在拥挤的市场中区分其产品并提供附加价值服务。

供应链中断导致疫苗浪费

儘管技术不断进步，但供应链漏洞仍然是一个威胁。设备故障、海关延误、交通基础设施不足以及停电造成的温度变化都会影响疫苗的有效性。世界卫生组织估计，全球有高达 50% 的疫苗被浪费，主要是因为处理或温度控制问题。结果，製造商和政府遭受经济损失，储存系统失去信誉。此外，低温运输性能不一致会阻碍对优质包装和储存创新的额外支出。

COVID-19的影响：

新冠疫情在全球范围内对精密包装和低温运输基础设施产生了前所未有的需求，对疫苗储存和包装市场产生了重大影响。辉瑞-BioNTech 和 Moderna 等公司的疫苗必须在极低的温度下储存，这些疫苗的快速研发和推出促使人们对专用冷冻库、隔热运输箱、干冰包装和即时监控系统进行投资。政府、製药公司和物流供应商的生产能力迅速扩张，带动市场蓬勃发展。此外，疫情暴露了中低收入国家低温运输能力的差距，刺激了全球对可携式节能储存设备的投资和进步。

预计塑胶产业在预测期内将成为最大的产业。

预计塑胶製品将在预测期内占据最大的市场占有率，因为它价格实惠、坚固耐用、便于携带，是广泛分发疫苗的理想选择。塑胶经常用于疫苗管瓶、注射器、安瓿瓶和二次包装，因为它们不易破碎，而这是玻璃的主要问题。疫苗包装常用的塑胶包括环烯烃共聚物 (COC)、聚丙烯 (PP) 和高密度聚苯乙烯(HDPE)，确保无菌并与各种疫苗製剂相容。此外，塑胶包装支援温控物流，聚合物基低温运输解决方案和专用绝缘容器的日益普及就证明了这一点。

预计预测期内 mRNA 疫苗部分将以最高的复合年增长率成长。

预计 mRNA 疫苗领域在预测期内将呈现最高的成长率。这是由于辉瑞-BioNTech和Moderna等新冠疫苗的成功以及生物技术的发展。这些疫苗必须在超低温（-70°C 至 -20°C）下储存，因此需要绝缘包装容器、温度监测设备和专门的低温运输包装解决方案。此外，由于mRNA技术在个人化医疗、癌症免疫治疗和感染疾病的快速应用，市场正在不断扩大。冷冻干燥配方的进步和脂质奈米颗粒稳定性的提高应该会减少储存需求，但超低温运输基础设施仍然至关重要。

占比最大的地区：

预计北美地区将在预测期内占据最大的市场占有率。这是由于政府实施了强有力的疫苗接种计划、疫苗产量高以及拥有先进的低温运输基础设施。辉瑞、Moderna 和强生等大型製药公司的存在，以及 FDA 和 CDC 的监管支持，增加了对专业储存和包装解决方案的需求。此外，透过完善的超低温链物流，该地区实现了新冠疫苗的大规模分发，进一步巩固了该地区的市场地位。

复合年增长率最高的地区：

预计亚太地区在预测期内的复合年增长率最高。这是在药品产量增加、低温运输基础设施加强和疫苗接种计划蓬勃发展的背景下实现的。为支持大规模疫苗接种工作，中国、印度和日本等国家正大力投资疫苗生产、温控物流和生技研发。由于政府采取措施改善医疗基础设施以及对感染疾病的需求不断增加，市场正在成长。此外，该地区的快速成长也得益于当地疫苗製造商的崛起以及绝缘包装容器和智慧标籤等尖端包装技术的使用。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球疫苗储存和包装市场（依产品类型）

  • 疫苗储存
    • 冰箱
    • 冷冻库
    • 低温储存装置
    • 超低温冷冻库
  • 疫苗包装
    • 冷却箱
    • 管瓶和安瓿瓶
    • 瓦楞纸箱
    • 包包
    • 其他疫苗包装

6. 全球疫苗储存与包装市场（依包装材料）

  • 塑胶
  • 玻璃
  • 纸和纸板
  • 金属
  • 其他包装材料

7. 全球疫苗储存和包装市场（依疫苗类型）

  • mRNA疫苗
  • DNA疫苗
  • 蛋白质疫苗
  • 病毒载体疫苗

8. 全球疫苗储存和包装市场（按应用）

  • 人类疫苗
  • 动物疫苗

9. 全球疫苗储存和包装市场（按最终用户）

  • 製药和生物技术公司
  • 诊断中心
  • 医院
  • 政府
  • 临床研究组织
  • 其他最终用户

第十章全球疫苗储存和包装市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Corning, Inc.
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • Stevanato Group
  • Dulas Ltd.
  • Azenta Inc.
  • Cardinal Health Inc.
  • PHC Holdings Corporation
  • Blue Star Limited
  • Panasonc Healthcare Co., Ltd
  • Nipro Corporation
  • Standex International Corporation
  • Eppendorf SE
  • Gerresheimer AG
  • Haier Biomedical
Product Code: SMRC29108

According to Stratistics MRC, the Global Vaccine Storage & Packaging Market is accounted for $40.06 billion in 2025 and is expected to reach $88.57 billion by 2032 growing at a CAGR of 12.0% during the forecast period. Vaccine storage and packaging play a critical role in maintaining the efficacy and safety of vaccines from production to administration. Cold chain logistics, or refrigeration systems that guarantee vaccines stay within a predetermined temperature range, are crucial because proper storage conditions, especially temperature control, are crucial to maintaining vaccine potency. Moreover, improved traceability and security have resulted from packaging innovations like tamper-evident seals and temperature-sensitive labels. Demand for reliable, effective, and sustainable vaccine storage and packaging solutions is going to increase as global immunization efforts spread, particularly in isolated and underdeveloped regions.

According to the Pan American Health Organization (PAHO), vaccine vial monitors (VVMs) are heat indicators that change color when exposed to temperatures above a specified threshold. There are five different types of VVMs, each designed for specific vaccines based on their heat stability. These VVMs are classified using three temperature thresholds: 37°C, 25°C, and 5°C.

Market Dynamics:

Driver:

Increasing worldwide immunization initiatives

One of the main factors propelling the vaccine storage and packaging market is the spread of immunization campaigns in both developed and developing nations. Every year, billions of dollars are spent on mass vaccination campaigns to combat diseases like measles, polio, HPV, and COVID-19 by groups like the World Health Organization (WHO), Gavi, and UNICEF. As of 2023, for instance, Gavi has facilitated the vaccination of more than 981 million children. Additionally, the need for specialized storage systems and protective packaging solutions is increased as a result of these efforts, which call for a highly dependable supply chain with stringent temperature and safety controls to guarantee vaccine potency.

Restraint:

High operating and capital expenses

Vaccine storage systems, especially those that use ultra-cold chain logistics, are expensive to set up and maintain. Particularly in environments with limited resources, specialized freezers, insulated containers, and monitoring equipment are costly to purchase and run. Recurring operating costs are also increased by the electricity needed to maintain constant low temperatures. Ultra-low temperature (ULT) freezers, for example, can cost anywhere from $10,000 to $25,000 per unit and use a lot more energy than conventional refrigeration systems. Furthermore, adoption may be restricted by these expenses, particularly in developing nations with limited resources and infrastructure, small hospitals, and rural clinics.

Opportunity:

Technological advancements in smart packaging

Real-time monitoring sensors, RFID tags, temperature-sensitive labels, and traceability enabled by QR codes are examples of smart packaging solutions that are becoming more and more popular. These technologies improve supply chain transparency, lower human error, and increase safety. For example, vaccination campaigns supported by the WHO now routinely use vaccine vial monitors (VVMs), which change color when exposed to heat. Moreover, businesses now have new ways to differentiate their products in a crowded market and offer value-added services by integrating IoT and AI-based tracking into packaging.

Threat:

Disruptions in the supply chain cause vaccine waste

Supply chain vulnerabilities continue to pose a threat in spite of technological advancements. The effectiveness of vaccines may be compromised by temperature excursions brought on by equipment failures, delays at customs, inadequate transportation infrastructure, and power outages. The WHO estimates that up to 50% of vaccines are thrown away worldwide, mostly as a result of handling and temperature control problems. Manufacturers and governments suffer financial losses as a result, and storage systems lose their credibility. Additionally, inconsistent cold chain performance discourages additional spending on upscale packaging and storage innovations.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the vaccine storage and packaging market by creating an unparalleled demand for sophisticated packaging and cold chain infrastructure worldwide. The quick development and widespread use of vaccines that needed to be stored at extremely low temperatures, such as Pfizer-BioNTech and Moderna, prompted investments in specialized freezers, insulated shippers, dry ice packaging, and real-time monitoring systems. Rapid capacity expansion by governments, pharmaceutical firms, and logistics providers led to a spike in market expansion. Furthermore, the pandemic brought to light deficiencies in cold chain capabilities in low- and middle-income nations, which led to global investment and advancements in portable and energy-efficient storage devices.

The plastic segment is expected to be the largest during the forecast period

The plastic segment is expected to account for the largest market share during the forecast period because of its affordability, robustness, and portability, which make it perfect for widespread vaccination distribution. Because of its resistance to breaking, which is a big issue with glass, it is frequently used in vaccine vials, syringes, ampoules, and secondary packaging. Common plastics used in vaccine packaging include cyclic olefin copolymer (COC), polypropylene (PP), and high-density polyethylene (HDPE), which guarantee sterility and compatibility with various vaccine formulations. Moreover, temperature-controlled logistics are supported by plastic packaging, as evidenced by the growing popularity of polymer-based cold chain solutions and specialized insulated containers.

The mRNA vaccines segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the mRNA vaccines segment is predicted to witness the highest growth rate, motivated by the success of COVID-19 vaccines like Pfizer-BioNTech and Moderna, as well as developments in biotechnology. Because these vaccines must be stored at extremely low temperatures (-70°C to -20°C), there is a greater need for insulated containers, temperature monitoring equipment, and specialized cold chain packaging solutions. Additionally, the market is expanding due to the quick uptake of mRNA technology in personalized medicine, cancer immunotherapy, and infectious diseases. Storage needs should be lessened by advancements in lyophilized (freeze-dried) formulations and enhanced lipid nano particle stability, but ultra-cold chain infrastructure is still crucial.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by robust government immunization programs, high vaccine production, and sophisticated cold chain infrastructure. The need for specialized storage and packaging solutions has increased due to the presence of major pharmaceutical companies like Pfizer, Moderna, and Johnson & Johnson as well as regulatory support from the FDA and CDC. Furthermore, the region's market position was further strengthened by the mass distribution of COVID-19 vaccines, which was made possible by its well-established ultra-cold chain logistics.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by growing pharmaceutical production, enhancing cold chain infrastructure, and quickly growing immunization programs. To support mass immunization efforts, nations like China, India, and Japan are making significant investments in vaccine production, temperature-controlled logistics, and biotechnology research and development. The market is expanding as a result of government initiatives to improve healthcare infrastructure and the rising demand for vaccines against infectious diseases. Moreover, the region's rapid growth is also facilitated by the emergence of regional vaccine producers and the use of cutting-edge packaging technologies like insulated shipping containers and smart labels.

Key players in the market

Some of the key players in Vaccine Storage & Packaging Market include Corning, Inc., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Stevanato Group, Dulas Ltd., Azenta Inc., Cardinal Health Inc., PHC Holdings Corporation, Blue Star Limited, Panasonc Healthcare Co., Ltd, Nipro Corporation, Standex International Corporation, Eppendorf SE, Gerresheimer AG and Haier Biomedical.

Key Developments:

In February 2025, Thermo Fisher Scientific Inc. announced that the company has entered into a definitive agreement with Solventum to acquire Solventum's Purification & Filtration business for approximately $4.1 billion in cash. Solventum's Purification & Filtration business is a leading provider of purification and filtration technologies used in the production of biologics as well as in medical technologies and industrial applications.

In October 2024, BD (Becton, Dickinson and Company) announced it has reached an agreement to resolve the vast majority of its existing hernia litigation. Terms of the settlement agreement, which are confidential, include cases in both the Rhode Island consolidated litigation and the federal multidistrict litigation in Ohio.

In August 2024, Corning Incorporated and Lumen have announced an agreement for a substantial supply of next-generation optical cable. The agreement reserves 10% of Corning's global fiber capacity for each of the next two years to interconnect AI-enabled data center.

Product Types Covered:

  • Vaccine Storage
  • Vaccine Packaging

Packaging Materials Covered:

  • Plastic
  • Glass
  • Paper & Paperboard
  • Metal
  • Other Packaging Materials

Vaccine Types Covered:

  • mRNA Vaccines
  • DNA Vaccines
  • Protein-Based Vaccines
  • Viral Vector Vaccines

Applications Covered:

  • Human Vaccines
  • Animal Vaccines

End Users Covered:

  • Pharma and Biotech Companies
  • Diagnostic Centers
  • Hospitals
  • Government Agencies
  • Clinical Research Organization
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Vaccine Storage & Packaging Market, By Product Type

  • 5.1 Introduction
  • 5.2 Vaccine Storage
    • 5.2.1 Refrigerators
    • 5.2.2 Freezers
    • 5.2.3 Cryogenic Storage Units
    • 5.2.4 Ultra-low Temperature Freezers
  • 5.3 Vaccine Packaging
    • 5.3.1 Cold Boxes
    • 5.3.2 Vials & Ampoules
    • 5.3.3 Corrugated Boxes
    • 5.3.4 Bags
    • 5.3.5 Other Vaccine Packagings

6 Global Vaccine Storage & Packaging Market, By Packaging Material

  • 6.1 Introduction
  • 6.2 Plastic
  • 6.3 Glass
  • 6.4 Paper & Paperboard
  • 6.5 Metal
  • 6.6 Other Packaging Materials

7 Global Vaccine Storage & Packaging Market, By Vaccine Type

  • 7.1 Introduction
  • 7.2 mRNA Vaccines
  • 7.3 DNA Vaccines
  • 7.4 Protein-Based Vaccines
  • 7.5 Viral Vector Vaccines

8 Global Vaccine Storage & Packaging Market, By Application

  • 8.1 Introduction
  • 8.2 Human Vaccines
  • 8.3 Animal Vaccines

9 Global Vaccine Storage & Packaging Market, By End User

  • 9.1 Introduction
  • 9.2 Pharma and Biotech Companies
  • 9.3 Diagnostic Centers
  • 9.4 Hospitals
  • 9.5 Government Agencies
  • 9.6 Clinical Research Organization
  • 9.7 Other End Users

10 Global Vaccine Storage & Packaging Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Corning, Inc.
  • 12.2 Thermo Fisher Scientific Inc.
  • 12.3 Becton, Dickinson and Company
  • 12.4 Stevanato Group
  • 12.5 Dulas Ltd.
  • 12.6 Azenta Inc.
  • 12.7 Cardinal Health Inc.
  • 12.8 PHC Holdings Corporation
  • 12.9 Blue Star Limited
  • 12.10 Panasonc Healthcare Co., Ltd
  • 12.11 Nipro Corporation
  • 12.12 Standex International Corporation
  • 12.13 Eppendorf SE
  • 12.14 Gerresheimer AG
  • 12.15 Haier Biomedical

List of Tables

  • Table 1 Global Vaccine Storage & Packaging Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Vaccine Storage & Packaging Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Vaccine Storage & Packaging Market Outlook, By Vaccine Storage (2024-2032) ($MN)
  • Table 4 Global Vaccine Storage & Packaging Market Outlook, By Refrigerators (2024-2032) ($MN)
  • Table 5 Global Vaccine Storage & Packaging Market Outlook, By Freezers (2024-2032) ($MN)
  • Table 6 Global Vaccine Storage & Packaging Market Outlook, By Cryogenic Storage Units (2024-2032) ($MN)
  • Table 7 Global Vaccine Storage & Packaging Market Outlook, By Ultra-low Temperature Freezers (2024-2032) ($MN)
  • Table 8 Global Vaccine Storage & Packaging Market Outlook, By Vaccine Packaging (2024-2032) ($MN)
  • Table 9 Global Vaccine Storage & Packaging Market Outlook, By Cold Boxes (2024-2032) ($MN)
  • Table 10 Global Vaccine Storage & Packaging Market Outlook, By Vials & Ampoules (2024-2032) ($MN)
  • Table 11 Global Vaccine Storage & Packaging Market Outlook, By Corrugated Boxes (2024-2032) ($MN)
  • Table 12 Global Vaccine Storage & Packaging Market Outlook, By Bags (2024-2032) ($MN)
  • Table 13 Global Vaccine Storage & Packaging Market Outlook, By Other Vaccine Packagings (2024-2032) ($MN)
  • Table 14 Global Vaccine Storage & Packaging Market Outlook, By Packaging Material (2024-2032) ($MN)
  • Table 15 Global Vaccine Storage & Packaging Market Outlook, By Plastic (2024-2032) ($MN)
  • Table 16 Global Vaccine Storage & Packaging Market Outlook, By Glass (2024-2032) ($MN)
  • Table 17 Global Vaccine Storage & Packaging Market Outlook, By Paper & Paperboard (2024-2032) ($MN)
  • Table 18 Global Vaccine Storage & Packaging Market Outlook, By Metal (2024-2032) ($MN)
  • Table 19 Global Vaccine Storage & Packaging Market Outlook, By Other Packaging Materials (2024-2032) ($MN)
  • Table 20 Global Vaccine Storage & Packaging Market Outlook, By Vaccine Type (2024-2032) ($MN)
  • Table 21 Global Vaccine Storage & Packaging Market Outlook, By mRNA Vaccines (2024-2032) ($MN)
  • Table 22 Global Vaccine Storage & Packaging Market Outlook, By DNA Vaccines (2024-2032) ($MN)
  • Table 23 Global Vaccine Storage & Packaging Market Outlook, By Protein-Based Vaccines (2024-2032) ($MN)
  • Table 24 Global Vaccine Storage & Packaging Market Outlook, By Viral Vector Vaccines (2024-2032) ($MN)
  • Table 25 Global Vaccine Storage & Packaging Market Outlook, By Application (2024-2032) ($MN)
  • Table 26 Global Vaccine Storage & Packaging Market Outlook, By Human Vaccines (2024-2032) ($MN)
  • Table 27 Global Vaccine Storage & Packaging Market Outlook, By Animal Vaccines (2024-2032) ($MN)
  • Table 28 Global Vaccine Storage & Packaging Market Outlook, By End User (2024-2032) ($MN)
  • Table 29 Global Vaccine Storage & Packaging Market Outlook, By Pharma and Biotech Companies (2024-2032) ($MN)
  • Table 30 Global Vaccine Storage & Packaging Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 31 Global Vaccine Storage & Packaging Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 32 Global Vaccine Storage & Packaging Market Outlook, By Government Agencies (2024-2032) ($MN)
  • Table 33 Global Vaccine Storage & Packaging Market Outlook, By Clinical Research Organization (2024-2032) ($MN)
  • Table 34 Global Vaccine Storage & Packaging Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.